Safety & Effectiveness of New Drug & Biological Products in Pediatric Patients | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2001-N-0106

Safety & Effectiveness of New Drug & Biological Products in Pediatric Patients

Documents

Comments

Description

CLOSED DATE: 01/23/2003 Docket Status: CLOSED

Type	Title	Posted	Comments	Status
Notice	Agency Information Collection Activities; Announcement of OMB Approval; Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients FR Doc: 03-1401	Jan 28, 2003	--

PEDIATRIC PATIENTS

OMB # 0910-0392

BIOLOGICAL PRODUCTS

COLLECTION ACTIVITIES

NEW DRUGS

AGENCY INFORMATION